Welcome to investors

Atticus Medical is a biotechnology company developing new medicines for diseases that affect disadvantaged communities.

Happy family walking together by a lake at sunset, featured in the hero section of the Investors Overview page on Atticus Medical.Purple and pink gradient abstract decorative pattern used on the homepage of Atticus Medical website.
Two teal downward arrows used as a decorative flair element on the Atticus Medical website.

Investor presentation

INVESTMENT IMPACT

A unique opportunity for global impact

Purple and pink gradient abstract decorative pattern used on the Investors Overview page of Atticus Medical website.Dark teal arrow pointing right, used to represent direct impact on the Investors Overview page of Atticus Medical.

Direct impact

Over 200 million people with scabies, headlice and demodex infestation would have access to a better medicine.

Purple and pink gradient abstract pattern with a transparent background, a secondary branding element for Atticus Medical.Small teal arrow pointing right and down, used as a design element on the Atticus Medical website.Small teal arrow pointing left, used as a design element on the Atticus Medical website.Small teal arrow pointing up, used as a design element on the Atticus Medical website.

Indirect impact

Our medicines are expected to reduce stigma, improve education outcomes and enhance the quality of life for both patients and their families.

Use of funds

Atticus Medical is working toward three key milestones

Scabies icon in navy on a lime green circle with a purple and pink gradient, featured on the homepage and disease focus modals of Atticus Medical.
Purple arrow pointing left, used as a design element on the homepage of the Atticus Medical website.
Small purple arrow pointing right, used as a design element on the homepage of the Atticus Medical website - mobile version.

Milestone 1

Regulatory approval of AM-2 for the treatment of scabies.

Small purple arrow pointing right, used as a design element on the homepage of the Atticus Medical website - mobile version.

Milestone 2

Selection of the most appropriate doses of AM-3 and AM-4 for treatment of demodex blepharitis and headlice.

Purple arrow pointing right, used as a design element on the homepage of the Atticus Medical website.
Demodex Blepharitis icon in navy on a lime green circle with a purple and pink gradient, featured on the homepage and disease focus modals of Atticus Medical.
Head lice icon in navy on a lime green circle with a purple and pink gradient, featured on the homepage and disease focus modals of Atticus Medical.
Purple arrow pointing left, used as a design element on the homepage of the Atticus Medical website.
Small purple arrow pointing right, used as a design element on the homepage of the Atticus Medical website - mobile version.

Milestone 3

Improving access to moxidectin by making it commercially available in major markets.

Corporate governance